The Medical Radiation Shielding Market can be segmented according to shielding material, radiation type, imaging modality, application, end user, and region.

By material, the market includes lead-based shielding, lead-free shielding, polymer-based shielding, composite shielding, and glass-based shielding. Lead remained the dominant material in 2025, accounting for approximately 76% of the market. However, non-lead composite materials are expected to grow rapidly during the forecast period.

By imaging and therapy modality, diagnostic radiology held the largest share, supported by the extensive use of X-ray and CT equipment. Nuclear medicine, radiotherapy, and proton therapy represent additional areas of demand.

By end user, hospitals represent the largest segment, accounting for approximately 66% of market size in 2025. Imaging centers, radiology practices, research institutions, veterinary facilities, and ambulatory surgery centers also contribute to market demand.

Regionally, North America held the largest share in 2025. Europe represents another major market, while Asia-Pacific is projected to achieve the highest regional CAGR of approximately 7.8% through 2035.

The diverse segmentation highlights the broad range of applications and growth opportunities available to manufacturers and service providers in the medical radiation shielding industry.